Jinying Jia

Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

HDAC and MEK inhibition synergistically suppresses HOXC6 and enhances PD-1 blockade efficacy in BRAFV600E-mutant microsatellite stable colorectal cancer.

HDAC and MEK inhibition synergistically suppresses HOXC6 and enhances PD-1 blockade efficacy in BRAFV600E-mutant microsatellite stable colorectal cancer.

Journal: Journal for immunotherapy of cancer
Published: December 06, 2024

UVRAG Promotes Tumor Progression through Regulating SP1 in Colorectal Cancer.

UVRAG Promotes Tumor Progression through Regulating SP1 in Colorectal Cancer.

Journal: Cancers
Published: March 20, 2023

FAP promotes metastasis and chemoresistance via regulating YAP1 and macrophages in mucinous colorectal adenocarcinoma.

FAP promotes metastasis and chemoresistance via regulating YAP1 and macrophages in mucinous colorectal adenocarcinoma.

Journal: iScience
Published: June 18, 2022

Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy.

Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy.

Journal: BMC cancer
Published: June 17, 2021

Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer.

Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer.

Journal: Journal for immunotherapy of cancer
Published: September 27, 2020

Tumor mutation burden in blood predicts benefit from neoadjuvant chemo/radiotherapy in locally advanced rectal cancer.

Tumor mutation burden in blood predicts benefit from neoadjuvant chemo/radiotherapy in locally advanced rectal cancer.

Journal: Genomics
Published: July 21, 2020

Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.

Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.

Journal: EBioMedicine
Published: July 05, 2018

Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer.

Enhancement of Sensitivity to Chemo/Radiation Therapy by Using miR-15b against DCLK1 in Colorectal Cancer.

Journal: Stem cell reports
Published: March 26, 2018

Somatic Mutations and Immune Alternation in Rectal Cancer Following Neoadjuvant Chemoradiotherapy.

Somatic Mutations and Immune Alternation in Rectal Cancer Following Neoadjuvant Chemoradiotherapy.

Journal: Cancer immunology research
Published: October 30, 2017

Prognostic value of pigment epithelium-derived factor for neoadjuvant radiation therapy in patients with locally advanced rectal carcinoma.

Prognostic value of pigment epithelium-derived factor for neoadjuvant radiation therapy in patients with locally advanced rectal carcinoma.

Journal: International journal of oncology
Published: March 31, 2016
Showing 1-10 of 10

Last Updated: 09/26/2026